Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta

Wranke A., Heidrich B., Ernst S., Serrano B. C., Caruntu F. A., Curescu M. G., ...Daha Fazla

PLOS ONE, cilt.9, sa.7, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9 Sayı: 7
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1371/journal.pone.0101002
  • Dergi Adı: PLOS ONE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Background: Hepatitis delta frequently leads to liver cirrhosis and hepatic decompensation. As treatment options are limited, there is a need for biomarkers to determine disease activity and to predict the risk of disease progression. We hypothesized that anti-HDV IgM could represent such a marker.